Avalo Therapeutics Inc (AVTX)
9.50
-0.14
(-1.45%)
USD |
NASDAQ |
May 17, 16:00
9.50
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Gross Profit (TTM): 0.796M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.796M |
| December 31, 2023 | 0.64M |
| September 30, 2023 | 0.124M |
| June 30, 2023 | 14.56M |
| March 31, 2023 | 14.09M |
| December 31, 2022 | 14.62M |
| September 30, 2022 | 14.14M |
| June 30, 2022 | 0.156M |
| March 31, 2022 | 3.962M |
| December 31, 2021 | 3.905M |
| September 30, 2021 | 5.528M |
| June 30, 2021 | 6.12M |
| Date | Value |
|---|---|
| March 31, 2021 | 4.108M |
| December 31, 2020 | 6.40M |
| September 30, 2020 | 5.518M |
| June 30, 2020 | 6.552M |
| March 31, 2020 | 8.181M |
| December 31, 2019 | 7.317M |
| September 30, 2019 | 2.604M |
| June 30, 2019 | 1.499M |
| March 31, 2019 | 1.972M |
| December 31, 2018 | 3.768M |
| September 30, 2018 | 9.543M |
| June 30, 2018 | 33.62M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
0.124M
Minimum
Sep 2023
14.62M
Maximum
Dec 2022
6.040M
Average
5.523M
Median
Gross Profit (TTM) Benchmarks
| Imunon Inc | -- |
| iBio Inc | -- |
| Kodiak Sciences Inc | -- |
| Petros Pharmaceuticals Inc | 4.191M |
| Ocugen Inc | -- |